SLE classification criteria: Is "The causality principle" integrated and operative - and do the molecular and genetical network, on which criteria depend on, support the definition of SLE as "a one disease entity" - A theoretical discussion

被引:3
作者
Rekvig, Ole Petter [1 ,2 ]
机构
[1] Furst Med Lab, Oslo, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway
关键词
Chromatin autoimmunity; Systemic lupus erythematosus; Lupus nephritis; Endonucleases; DNase; 1; The causality principle; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTINUCLEAR ANTIBODIES; REVISED CRITERIA; DNA ANTIBODIES; HEAVY-CHAIN; ANTI-DSDNA; NEPHRITIS; MURINE; AUTOANTIBODY; NUCLEOSOMES;
D O I
10.1016/j.autrev.2023.103470
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Molecular and cellular aspects of the autoimmune pathophysiology in SLE is linked to the "The causality principle". SLE Classification Criteria identify per definition disease measures (here: synonymous with classification criteria), but not diagnostic criteria within a classical framework. These two mostly theoretical criteria collections represent a salient conflict between phenomenology and the causality principle - between disease measures and molecular interactions that promote such measures, in other words their cause(s). Essentially, each criterion evolves from immunogenic and inflammatory signals - some are interconnected, some are not. Disparate signals instigated by disparate causes. These may promote clinically heterogenous SLE cohorts with respect to organ affection, autoimmunity, and disease course. There is today no concise measures or arguments that settle whether SLE cohorts evolve from one decisive etiological factor (homogenous cohorts), or if disparate pathobiological factors promote SLE (heterogenous cohorts). Current SLE cohorts are not ideal substrates to serve as study objects if the research aims are to describe etiology, and molecular interactions that cause - and link primary and secondary pathophysiological events together - events that account for early and progressive SLE. We have to develop SLE criteria allowing us to identify definable categories of SLE in order to describe etiology, pathophysiology and diagnostic criteria of delimitated SLE versions. In this regard, the causality principle is central to define dominant etiologies of individual SLE categories, and subsequent and consequent down-stream diagnostic disease measures. In this sense, we may whether we like it or not identify different SLE categories like "genuine SLE" and "SLE-like non-SLE" syndromes. Many aspects of this problem are thoroughly discussed in this study.
引用
收藏
页数:11
相关论文
共 111 条
  • [71] Evolving story of autoantibodies in systemic lupus erythematosus
    Pisetsky, David S.
    [J]. JOURNAL OF AUTOIMMUNITY, 2020, 110
  • [72] A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus
    Pisetsky, David S.
    Clowse, Megan E. B.
    Criscione-Schreiber, Lisa G.
    Rogers, Jennifer L.
    [J]. ARTHRITIS CARE & RESEARCH, 2019, 71 (06) : 735 - 741
  • [73] Anti-DNA antibodies - quintessential biomarkers of SLE
    Pisetsky, David S.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (02) : 102 - 110
  • [74] RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415
  • [75] Receptor editing, immune diversification, and self-tolerance
    Radic, MZ
    Zouali, M
    [J]. IMMUNITY, 1996, 5 (06) : 505 - 511
  • [76] Mechanisms of disease: Systemic lupus erythematosus
    Rahman, Anisur
    Isenberg, David A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (09) : 929 - 939
  • [77] Future Perspectives on Pathogenesis of Lupus Nephritis Facts, Problems, and Potential Causal Therapy Modalities
    Rekvig, Ole P.
    Thiyagarajan, Dhivya
    Pedersen, Hege L.
    Horvei, Kjersti D.
    Seredkina, Natalya
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (11) : 2772 - 2782
  • [78] The anti-DNA antibody: origin and impact, dogmas and controversies
    Rekvig, Ole P.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (09) : 530 - 540
  • [79] SLE classification criteria: Science-based icons or algorithmic distractions - an intellectually demanding dilemma
    Rekvig, Ole Petter
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [80] The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis
    Rekvig, Ole Petter
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 12